14 . 10 .2026
Press release
Galderma signs agreement to acquire ZO Skin Health, strengthening its physician-dispensed skincare offering
13 . 10 .2026
Press release
New Galderma research reveals more than half of women mistake menopause-related skin changes for signs of ageing
08 . 10 .2026
Press release
Fall Clinical 2026: Galderma presents new three-year Nemluvio® data showing deep and lasting skin lesion and itch responses in patients with atopic dermatitis aged 12 and older
07 . 10 .2026
News story
For menopause-related skin changes, aesthetic treatments are gaining ground
06 . 10 .2026
Press release
30 years of Restylane®: reshaping the aesthetics field through science-led, patient-centric innovation
30 . 09 .2026
Press release
EADV 2026: Galderma’s new data show sustained improvements with Nemluvio® (nemolizumab) for up to three years in patients with moderate-to-severe atopic dermatitis
23 . 09 .2026
Press release
EADV 2026: Galderma to unveil new data advancing understanding of skin diseases, skin longevity, and real-world patient experiences
21 . 09 .2026
Press release
Galderma begins trading in the Swiss Market Index, joining Switzerland's leading blue chip companies